Acute Myeloid Leukemia Patients Have Reduced Early Mortality at NCI-Designated Cancer Centers

Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the...
8-Mar-2018 3:30 PM EST Add to Favorites

There’s an App for That

UC Davis pathologist Hooman Rashidi is an expert in blood disorders but also a computer programmer. He has married the two disciplines and created must-have learning tools for medical students and residents. His latest is HemeQuiz1, a medical...
14-Feb-2018 4:00 PM EST Add to Favorites

Unlocking the Genetics of Cancer

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives.
28-Nov-2017 3:05 PM EST Add to Favorites

The Understudied Consequences of Peripheral Neuropathy after Chemotherapy

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother...
29-Aug-2017 8:05 AM EDT Add to Favorites

UC Davis-Led Group Receives $17 Million in NCI Funds

Breast Cancer Surveillance Consortium (BCSC) investigators have received a $17 million program project grant renewal from the National Cancer Institute to study the effectiveness of different breast cancer screening and surveillance strategies using...
19-Jul-2017 6:05 PM EDT Add to Favorites

How Treating a Dog's Tumors May Help in the Fight Against Human Cancer

With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.
6-Jul-2017 2:00 PM EDT Add to Favorites

Second Cancers Deadlier in Young Patients

Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers...
18-Apr-2017 2:00 PM EDT Add to Favorites

Hitting Cancer with High-Intensity Ultrasound and Immunotherapy

In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse...
23-Mar-2017 3:05 PM EDT Add to Favorites

see all news